Progetto

Punteggio progetto

Punteggio CV e struttura

Punteggio finale

Liquid biopsy: circulating/serum microRNA as novel non invasive prognostic biomarkers in Diffuse Large-B cell Lymphoma.

21

7

28

Transferrin Receptor 2 in Myelodysplastic Syndromes: beyond iron metabolism regulation.

16

12.9

28.9

Notch-ligand alterations in chronic lymphocytic leukemia: improving biological characterization

and targeted therapies.

16

11.2

27.2

Platelet dysfunction caused by ibrutinib and new generation Bruton tyrosine kinase inhibitors in patients with chronic lymphocytic leukemia: identification of patients at high risk of bleeding and potential reversal by desmopressin administration.

25

11.3

36.3

Effect of immunomodulatory drugs on antigen presenting cells: a possible mechanism to increase the allo-reactivity in multiple myeloma patients.

20

10

30

Circulating tumor DNA to monitor minimal residual disease in a prospective, multicenter, Fondazione Italiana Linfomi (FIL) study for DLBCL.

21

14.1

35.1

Use of blood platelets as siRNA vectors for silencing the bcr-abl fusion gene in Chronic Myeloid Leukemia (CML): in vivo application.

17

10.2

27.2

Exploring the role of pre B cell leukemia homeobox 1 (Pbx1) in myeloproliferative neoplasms.

26

10.3

36.3

Off-targets effects of Tyrosine Kinase Inhibitors on Dendritic Cells in patients with Chronic Myeloid Leukemia.

10

9.9

19.9

Bone marrow mesenchymal stem cell in lymphomas.

10

8

18